Transthyretin monomers: a new plasma biomarker for pre-symptomatic transthyretin-related amyloidosis.

Diogo Costa-RodriguesJosé P LeiteMaria João SaraivaMaria Rosário AlmeidaLuís Gales

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2024)

Monomeric TTR can function as a biomarker for evaluating disease progression and assessing responses to therapies targeted at stabilising native TTR.

Keyphrases

wild type
cancer therapy